Effects of glucagon-like peptide-1 analog liraglutide on the systemic inflammation in high-fat-diet-induced mice

被引：0
|
作者：
Sha Sha
Xiaoming Liu
Ruxing Zhao
Li Qing
Qin He
Lei Sun
Li Chen
机构：
[1] Qilu Hospital of Shandong University,Department of Endocrinology
[2] Institute of Endocrine and Metabolic Diseases of Shandong University,Key Laboratory of Endocrine and Metabolic Diseases
[3] Shandong Province medicine& health,undefined
来源：
Endocrine | 2019年 / 66卷
关键词：
Obesity; Immune; GLP-1; Metabolic syndrome;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：494 / 502
页数：8
相关论文
共 50 条
  • [21] Glucagon-like peptide-1, a matter of taste?
    Mojca Jensterle
    J. Hans DeVries
    Tadej Battelino
    Saba Battelino
    Bulent Yildiz
    Andrej Janez
    Reviews in Endocrine and Metabolic Disorders, 2021, 22 : 763 - 775
  • [22] Sleep is increased by liraglutide, a glucagon-like peptide-1 receptor agonist, in rats
    Fang, Jidong
    Miller, Patti
    Grigson, Patricia S.
    BRAIN RESEARCH BULLETIN, 2023, 192 : 142 - 155
  • [23] Liraglutide: A once-daily human glucagon-like peptide-1 analogue
    Aimaretti, G.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2009, 32 (08) : 701 - 703
  • [24] A glucagon-like peptide-1 analog, liraglutide, ameliorates endothelial dysfunction through miRNAs to inhibit apoptosis in rats
    Zhang, Qian
    Xiao, Xinhua
    Zheng, Jia
    Li, Ming
    PEERJ, 2019, 7
  • [25] Efficacy and safety of high-dose glucagon-like peptide-1, glucagon-like peptide-1/glucose-dependent insulinotropic peptide, and glucagon-like peptide-1/glucagon receptor agonists in type 2 diabetes
    De Block, Christophe E. M.
    Dirinck, Eveline
    Verhaegen, Ann
    Van Gaal, Luc F.
    DIABETES OBESITY & METABOLISM, 2022, 24 (05) : 788 - 805
  • [26] Mechanisms for the cardiovascular effects of glucagon-like peptide-1
    Poudyal, H.
    ACTA PHYSIOLOGICA, 2016, 216 (03) : 277 - 313
  • [27] Cardiometabolic Effects of Glucagon-Like Peptide-1 Agonists
    Sarraju, Ashish
    Kim, Sun H.
    Knowles, Joshua W.
    CURRENT ATHEROSCLEROSIS REPORTS, 2016, 18 (02) : 1 - 8
  • [28] The effects of glucagon-like peptide-1 on the beta cell
    Vilsboll, T.
    DIABETES OBESITY & METABOLISM, 2009, 11 : 11 - 18
  • [29] Nobiletin ameliorates high fat-induced disruptions in rhythmic glucagon-like peptide-1 secretion
    Martchenko, Alexandre
    Biancolin, Andrew D.
    Martchenko, Sarah E.
    Brubaker, Patricia L.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [30] ANTIDIABETOGENIC ACTION OF TRUNCATED GLUCAGON-LIKE PEPTIDE-1 IN MICE
    AHREN, B
    ENDOCRINE, 1995, 3 (05): : 367 - 369
12345